111 related articles for article (PubMed ID: 16321727)
1. The schizophrenia prodrome: a developmentally informed review and update for psychopharmacologic treatment.
Thomas LE; Woods SW
Child Adolesc Psychiatr Clin N Am; 2006 Jan; 15(1):109-33. PubMed ID: 16321727
[TBL] [Abstract][Full Text] [Related]
2. Early intervention in patients at ultra high risk of psychosis: benefits and risks.
de Koning MB; Bloemen OJ; van Amelsvoort TA; Becker HE; Nieman DH; van der Gaag M; Linszen DH
Acta Psychiatr Scand; 2009 Jun; 119(6):426-42. PubMed ID: 19392813
[TBL] [Abstract][Full Text] [Related]
3. Analysis of clinical characteristics and antipsychotic medication prescribing practices of first-episode schizophrenia in Israel: a naturalistic prospective study.
Strous RD; Bar F; Keret N; Lapidus R; Kosov N; Chelben J; Kotler M
Isr J Psychiatry Relat Sci; 2006; 43(1):2-9. PubMed ID: 16910378
[TBL] [Abstract][Full Text] [Related]
4. An update on pharmacologic treatments for autism spectrum disorders.
King BH; Bostic JQ
Child Adolesc Psychiatr Clin N Am; 2006 Jan; 15(1):161-75. PubMed ID: 16321729
[TBL] [Abstract][Full Text] [Related]
5. Review of the evidence for the long-term efficacy of atypical antipsychotic agents in the treatment of patients with schizophrenia and related psychoses.
Turner MS; Stewart DW
J Psychopharmacol; 2006 Nov; 20(6 Suppl):20-37. PubMed ID: 17046985
[TBL] [Abstract][Full Text] [Related]
6. Racial differences in the use of adjunctive psychotropic medications for patients with schizophrenia.
Mallinger JB; Lamberti SJ
J Ment Health Policy Econ; 2007 Mar; 10(1):15-22. PubMed ID: 17417044
[TBL] [Abstract][Full Text] [Related]
7. Impaired sensorimotor gating of the acoustic startle response in the prodrome of schizophrenia.
Quednow BB; Frommann I; Berning J; Kühn KU; Maier W; Wagner M
Biol Psychiatry; 2008 Nov; 64(9):766-73. PubMed ID: 18514166
[TBL] [Abstract][Full Text] [Related]
8. [Polypharmacy in the treatment of schizophrenia].
Messer T; Tiltscher C; Schmauss M
Fortschr Neurol Psychiatr; 2006 Jul; 74(7):377-91. PubMed ID: 16804806
[TBL] [Abstract][Full Text] [Related]
9. [Specific features and problems in the pharmacotherapy of schizophrenic psychoses in children and adolescents].
Fegert JM
Z Arztl Fortbild Qualitatssich; 2002 Oct; 96(9):597-603. PubMed ID: 12474310
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care.
Stargardt T; Weinbrenner S; Busse R; Juckel G; Gericke CA
J Ment Health Policy Econ; 2008 Jun; 11(2):89-97. PubMed ID: 18509216
[TBL] [Abstract][Full Text] [Related]
11. Toward a better identification and treatment of schizophrenia prodrome.
Bota RG; Sagduyu K; Filin EE; Bota DA; Munro S
Bull Menninger Clin; 2008; 72(3):210-27. PubMed ID: 18990056
[TBL] [Abstract][Full Text] [Related]
12. Strategies for the long-term treatment of schizophrenia: real-world lessons from the CATIE trial.
Meyer JM
J Clin Psychiatry; 2007; 68 Suppl 1():28-33. PubMed ID: 17286525
[TBL] [Abstract][Full Text] [Related]
13. [Clozapine in the treatment of under-age schizophrenia].
Haapasalo-Pesu KM
Duodecim; 2009; 125(15):1635-8. PubMed ID: 19769179
[TBL] [Abstract][Full Text] [Related]
14. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
Wheeler AJ
Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732
[TBL] [Abstract][Full Text] [Related]
15. Use and safety of antipsychotic drugs during pregnancy.
Einarson A; Boskovic R
J Psychiatr Pract; 2009 May; 15(3):183-92. PubMed ID: 19461391
[TBL] [Abstract][Full Text] [Related]
16. Early intervention and the treatment of prodrome in schizophrenia: a review of recent developments.
Mokhtari M; Rajarethinam R
J Psychiatr Pract; 2013 Sep; 19(5):375-85. PubMed ID: 24042243
[TBL] [Abstract][Full Text] [Related]
17. Duration of untreated psychosis and it's effect on the symptomatic recovery in schizophrenia - preliminary results.
Novak Sarotar B; Pesek MB; Agius M; Kocmur M
Neuro Endocrinol Lett; 2008 Dec; 29(6):990-4. PubMed ID: 19112411
[TBL] [Abstract][Full Text] [Related]
18. Review: Combination therapy with non-clozapine atypical antipsychotic medication: a review of current evidence.
Chan J; Sweeting M
J Psychopharmacol; 2007 Aug; 21(6):657-64. PubMed ID: 17092976
[TBL] [Abstract][Full Text] [Related]
19. The New York high risk project to the Hillside recognition and prevention (RAP) program.
Cornblatt BA
Am J Med Genet; 2002 Dec; 114(8):956-66. PubMed ID: 12457393
[TBL] [Abstract][Full Text] [Related]
20. Preventing clinical deterioration in the course of schizophrenia: the potential for neuroprotection.
Lieberman JA; Malaspina D; Jarskog LF
CNS Spectr; 2006 Apr; 11(4):suppl 1-13; quiz suppl 14-5. PubMed ID: 16641837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
